By Emeritus Professor Allan David Spigelman

Conference Papers

Talseth-Palmer BA; Brenne IS; Ashton K; Evans TJ; McPhillips M; Groombridge C; Kurzawski G; Spigelman A; Lubinski J; Scott RJ, 2010, 'Colorectal cancer susceptibility loci on chr 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, NORWAY, Oslo, pp. 22 - 22, presented at 21st Meeting of the European-Association-for-Cancer-Research, NORWAY, Oslo, 26 June 2010 - 29 June 2010, http://dx.doi.org/10.1016/S1359-6349(10)70892-2

McGrath D; Frydoonfar H; Spigelman AD, 2007, 'Potential mechanisms for the chemoprotective effect of cruciferous vegetables in colorectal cancer: A clinical trial of indole-3-carbinol', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, NETHERLANDS, Amsterdam, pp. 41 - 41, presented at 5th International Symposium onTargeted Anticancer Therapies, NETHERLANDS, Amsterdam, 08 March 2007 - 10 March 2007, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249280500076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Notarianni LJ; Oliver S; Bennett PN; Farmer KC; Spigelman A; Phillips RK, 1992, 'P4501A2 activity in patients with colorectal carcinoma and familial adenomatous polyposis (FAP) and their at risk relatives', in British Journal of Clinical Pharmacology

Back to profile page